Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Real-time Estimate Cboe BZX 10:42:42 2026-10-14 am EDT			5-day change	1st Jan Change
51.79 ^USD	+0.25%		+0.14%	+39.39%

08:21am	Wedbush Raises Price Target on IMAX to $60 From $54, Keeps Outperform Rating	MT
Oct. 08	Disney Holds Talks With Paramount, Universal on Using Imax Rival	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

856c6fb5850ae844f212511606b20.3P4nLiQ8_ns9HBx2D3U3x6Kz5Z70Dfrvhso_BlZ2MkE.qchWW3UKxxhFU1cQazYFnuWDo-i9PbaG1JNvVBQuWQeRlkhrFmu7OEgsaw~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

08:21am	Wedbush Raises Price Target on IMAX to $60 From $54, Keeps Outperform Rating	MT
Oct. 08	B. Riley Raises Price Target on IMAX to $64 From $61, Keeps Buy Rating	MT
Sep. 24	Morgan Stanley Initiates IMAX at Overweight With $63 Price Target	MT
Aug. 24	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
Jul. 24	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT
Jul. 24	Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating	MT
Jul. 24	B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating	MT
Jul. 24	Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating	MT
Jul. 16	IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says	MT
Jul. 16	Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47	MT
Jul. 10	B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating	MT
May. 18	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
May. 04	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
May. 01	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
Apr. 23	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
Apr. 17	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
Feb. 27	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
Feb. 26	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
Feb. 26	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
Dec. 15	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
Dec. 08	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
Dec. 08	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
Dec. 08	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT
Dec. 08	B. Riley Raises Price Target on IMAX to $44 From $40, Keeps Buy Rating	MT
Nov. 25	Goldman Sachs Upgrades IMAX to Neutral From Sell, Adjusts Price Target to $34 From $22	MT

More recommendations

Other Entertainment Production

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	IMAX CORPORATION					+9.85%
	LIVE NATION ENTERTAINMENT, INC.					+18.01%
	UNIVERSAL MUSIC GROUP N.V.					+39.91%
	ROKU, INC.					+6.33%
	WARNER MUSIC GROUP CORP.					+30.79%
	TKO GROUP HOLDINGS, INC.					+33.23%
	BOLLORÉ SE					+13.48%
	PARAMOUNT SKYDANCE CORPORATION					+1.64%
	MADISON SQUARE GARDEN SPORTS CORP.					+18.93%
	TOHO CO., LTD.					+13.12%
	Average					+18.53%
	Weighted average by Cap.					+21.22%